President Trump and President-elect Joe Biden both celebrated the news that a coronavirus vaccine developed by Pfizer and Bioentech has been found to be more than 90% effective in preventing COVID-19 in their Phase 3 clinical trials.
Development is an important step in the fight against the global epidemic at a time when cases are on the rise in many areas.
The Badon Coronavirus team to include Reed Bright, H. Physical H.H.S.
“The stock market is very big, with the advent of vaccines. Report 90% effective. Very good news! “Trump tweeted Monday morning.
Biden also celebrated the success of the trial, but also warned that the epidemic has been a problem and will probably continue until next month. Will remain the same.
“I congratulate the brilliant women and men who helped make this progress and gave us such a reason for hope,” Biden said in a statement. “At the same time, it is important to understand that the fight against COVID-19 is still months away. The news follows a timeline previously announced by industry officials that predicts vaccine approval in late November. If it is received, and some Americans are vaccinated later this year, it will still be several months before widespread vaccination takes place in this country. ”
Biden reminded Americans to continue wearing masks and practice social distance and other preventive measures.
U.S. These states are close to 10 million coronavirus cases in impact with the hardest heat.
The vaccine requires two doses and the trial, which began July 27, involved 38,955 participants who took a second dose by Sunday.
The heads of Pfizer and Bioentech celebrated their progress as a cause for hope.
“Today is a great day for science and humanity. The first set of results from our Phase 3 COVID-19 vaccine trial provides initial evidence of our vaccine’s ability to prevent COVID-19, ”said Pfizer Chairman and CEO Dr. Al. Albert Borla said in a statement. “We are reaching this critical milestone in our vaccine development program as infection rates set new records when the world needs it most, with nearby hospitals with more capacity and struggles to reopen. With today’s news, we are close to a significant step towards providing much-needed progress to people around the world to help end this global health crisis. “
Click here to get the Fox News app
Ugur Sahin, CEO and co-founder of Bionettech, called the trial a “victory for innovation, science and global collaborative efforts” and said it was “in the midst of another wave and in many of us lockdowns. We appreciate how important this is.” This is the way to end the epidemic and bring a sense of normalcy to all of us.
The companies expect to produce about 50 million doses of the vaccine this year and up to 1.3 billion next year.
